Pilot Funding
Pilot Funding
Pilot and Collaborative Translation and Clinical Studies
The overall goal of
the Pilot and Collaborative Translational and Clinical Studies Program is to foster
the development of innovative translational and clinical research by leveraging
multiple existing sources of pilot funding for our membership and creating new funding
programs that fill existing gaps. To accomplish this goal we have created an
ITHS Center
for Scientific Review (CSR). The ITHS CSR will provide a significant source of new
funding for pilot and collaborative studies. Funding priorities include projects
proposed by junior faculty or senior faculty with new research emphases, by inter-
or multidisciplinary teams, by scientists partnering with industry to develop new
technologies, and by community-based investigators.
Research applications will be reviewed by one of five scientific review committees—the
(a) Clinical Research Center Network (CRCN) Usage and Ancillary Awards, (b) Small
Grants, (c) Drug and Device Development, (d) Technology and Resources Access, and
(e) Community Partnerships review committees—all managed under the ITHS CSR umbrella.
CRCN Usage and Ancillary
Awards Review Committee—This
committee replaces the UW GCRC Scientific Advisory
Committee and the CHMRC Pediatric Scientific Advisory Committee. Applications for
usage of any of the CRCN research units will be considered, as well as requests
for ancillary support.
Applications due monthly. CHMRC: 10th of the month, UW: 25th of the month.
Small Grants Review Committee—This committee reviews pilot grants pertaining to any aspect of translational health science (e.g., development of a serum-based test to diagnose colon cancer in patients with ulcerative colitis; novel bioinformatics systems for analyzing proteomic data; testing community-based translation- and dissemination models for efficacious obesity-prevention programs). Additionally, projects using novel evaluation methods and proposing research on the translational research project will be considered These include applying innovative evaluation techniques to better understand the translational research process, including aspects of collaborative functioning, successful career development, and dissemination and adoption of innovations
Applications due Feb. 1, May 1, Nov. 1
Drug and Device Development Review Committee—This committee will review applications from scientists developing novel products or scientists partnering with industry to develop new technologies. Projects that focus on clinical tests/diagnostics/therapeutics that have the potential to speed translational research, decrease the cost of healthcare, or improve clinical treatments will be considered.
Applications (abstracts) due Feb. 29 for non-human primate research; future topics and deadlines under development.
Technology and Resources Access Review Committee—This committee will review applications for grants that will subsidize the costs of services provided by ITHS-affiliated resource cores. Access to specific technologies (e.g., genotyping, microarrays, proteomics, imaging, flow cytometry, diet and nutrition assistance, human tissue acquisition, polysomnography) will be provided as a means for investigators to obtain preliminary and pilot data.
Applications due Feb. 1, May 1, Nov. 1
Community Partnerships Review Committee—This committee will review research applications submitted by tribal or non-tribal organization, community groups, and practices in the WWAMI region. Any research or research capacity-building effort related to clinical or translational health sciences by a community researcher will be considered.
(Under development)
Director:
Cathryn Booth-LaForce, PhD, FAPS, RYT
The Charles and Gerda Spence Endowed Professor in Nursing
Adjunct Professor, Psychology
Affiliate, Center on Human Development and Disability
Family and Child Nursing
Box 357920
University of Washington
Seattle, WA 98195-7920
Email Address:
ibcb@u.washington.edu